Microglia cells depend on CSF1R signaling [111, 112] and treatment of AD mice with CSF1R inhibitors results in reduced microglia activation and improved memory function [70, 113], but little is known about the cells that contribute to CSF1R triggering in AD. The gene discussed is CSF1R; the disease is Alzheimer disease.